Carvedilol
Product Images NDC 54868-3062

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 54868-3062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (3.125 mg)

The label for Carvedilol tablets by Physicians Total Care, Inc. displays a dosage strength of 3.125 mg with 30 tablets per bottle. It includes usage cautions and storage instructions, noting the tablets should be kept out of reach of children and stored below 30°C. The label also shows lot and expiration date information, accompanied by a barcode.*

FDA Label Image

Package Label-principal Display Panel (6.25 mg)

Carvedilol 6.25 mg oral tablets packaging label from Physicians Total Care, Inc. The label indicates 30 tablets per container. It includes cautionary information about federal law prohibiting dispensing without a prescription, dosage instructions to read carefully, and storage directions. Additional labeling details include the lot number, expiration date, manufacturing and packaging information, and a barcode.*

FDA Label Image

Package Label-principal Display Panel (12.5 mg)

Carvedilol 12.5 mg tablet bottle label from Physicians Total Care, Inc. The label includes dosage strength, quantity (100 tablets), NDC number, lot number, expiration date, storage instructions, and a caution that federal law prohibits dispensing without a prescription.*

FDA Label Image

Package Label-principal Display Panel (25 mg)

Carvedilol 25 mg tablets bottle label from Physicians Total Care, Inc. The label states the bottle contains 60 tablets. It includes dosage instructions to take one tablet twice daily, caution about food prohibitions, lot number, expiration date, and storage instructions to keep the container tightly closed and store at controlled room temperature.*

FDA Label Image

Figure 1. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig1)

A line graph comparing percent mortality over 24 months between Carvedilol and placebo groups. The x-axis represents months, and the y-axis shows percentage mortality. The graph indicates lower mortality rates in the Carvedilol group compared to placebo, with a noted p-value of 0.03.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig2)

A forest plot chart showing hazard ratios for various subgroups related to Carvedilol treatment. The subgroups include age, gender, timing post-myocardial infarction, prior beta-blocker use, Killip class, thrombolytic therapy, PTCA, congestive heart failure status, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. Hazard ratio values and confidence intervals are plotted along a horizontal axis from 0.4 to 1.3.*

FDA Label Image

Chemical Structure (Carvedilol Str)

Chemical structure diagram of Carvedilol, showing its molecular framework including benzodioxane, carbazole, and methoxyphenyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.